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Legionella pneumophila, the causative agent of Legionnaires’ disease, expresses a type IVB secretion appa-
ratus that translocates bacterial proteins into amoeba and macrophage hosts. When stationary-phase cultures
are used to infect hosts, the type IVB apparatus encoded by the icm/dot genes is required for entry, delay of
phagosome-lysosome fusion, and intracellular multiplication within host cells. Null mutants with mutations in
icm/dot genes are defective in these phenotypes. Here a new model is described in which hosts are infected with
stationary-phase cultures that have been incubated overnight in pH 6.5 buffer. This model is called Ers treat-
ment because it enhances the resistance to acid, hydrogen peroxide, and antibiotic stress beyond that of
stationary-phase cultures. Following Ers treatment entry into amoeba and macrophage hosts does not require
dotA, which is essential for Legionella virulence phenotypes when hosts are infected with stationary-phase
cultures, dotB, icmF, icmV, or icmX. Defective host entry is also suppressed for null mutants with mutations in
the KatA and KatB catalase-peroxidase enzymes, which are required for proper intracellular growth in amoeba
and macrophage hosts. Ers treatment-induced suppression of defective entry is not associated with increased
bacterial adhesion to host cells or with morphological changes in the bacterial envelope but is dependent on
protein expression during Ers treatment. By using proteomic analysis, Ers treatment was shown to induce a
protein predicted to contain eight tetratricopeptide repeats, a motif previously implicated in enhanced entry of
L. pneumophila. Characterization of Ers treatment-dependent changes in expression is proposed as an avenue
for identifying icm/dot-independent factors that function in the entry of Legionella into amoeba and macrophage
hosts.
Legionella pneumophila, the causative agent of Legionnaires’
disease, is a facultative intracellular pathogen found in aquatic
environments as planktonic cells, in biofilms, and as an intra-
cellular parasite of amoebae (14, 61, 62). When internalized by
alveolar macrophages (54), L. pneumophila resides in special-
ized phagosomes that are delayed in fusion with lysosomes and
are permissive to bacterial replication (78, 81). Formation of
the specialized phagosomes is attributed to proteins secreted
into the host (16, 23, 48, 53) by a type IVB secretion apparatus
encoded by the icm/dot loci (intracellular multiplication/defec-
tive organelle trafficking) (63, 69, 73, 80). Null mutants with
mutations in icm/dot genes are defective in entry into macro-
phage and amoeba hosts, intracellular multiplication, delay of
phagosome-lysosome fusion, and host cell killing (11, 39, 63,
66, 70, 80). Involvement of non-icm/dot factors in Legionella
virulence is implicated by mutations outside the icm/dot loci
associated with defective intracellular multiplication and host
cell killing. Such mutations implicate type II secretion, iron
sequestration, pilin synthesis, hydrogen peroxide decomposi-
tion, amino acid biosynthesis, and sugar transport (5, 17, 80).
Delayed fusion of Legionella-containing phagosomes with ly-
sosomes requires type IVB secretion. However, type IVB se-
cretion is not required for the delayed acquisition of certain
lysosomal markers, which occurs in phagosomes containing
mutants with mutations in dotA and dotB, which are considered
essential for type IVB secretion (43, 79). These data implicate
the presence of icm/dot-independent virulence factors, which
are poorly defined.
The importance of environmental stress in the transition of
L. pneumophila from environmental bacterium to intracellular
pathogen is supported by several lines of evidence. Nutrient,
thermal, and osmotic stresses are imposed in the environmen-
tal reservoirs from which Legionnaires’ disease is spread, in-
cluding water cooling towers, hot water tanks, and evaporative
condensers of air conditioning systems. Increased resistance to
antibiotics, to biocides, and to acid, H2O2, osmotic, and ther-
mal stresses following growth within amoebae (19, 20, 62)
suggests that stress is imposed by environmental amoeba hosts
(2, 29, 32, 38, 74, 80) belonging to the genera Acanthamoeba
and Hartmannella (14, 62). Stress genes are induced when
Legionella is grown in amoebae or in macrophage hosts (1, 2,
59; M. Miyaki, T. Fukui, Y. Imai, and H. A. Shuman, Abstr.
103th Gen. Meet. Am. Soc. Microbiol., abstr. B-013, 2003).
Participants in the oxidative stress response, the KatA and
KatB catalase-peroxidase enzymes, are required for optimal
intracellular multiplication in macrophages (5). Finally, the
stress of growth to the stationary phase endows L. pneumophila
with a full panel of virulence traits compared to rapidly divid-
ing exponential cultures, which are essentially avirulent (15).
We report here a new model for studying the effect of stress
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on entry of L. pneumophila into amoebae and macrophages:
overnight incubation of stationary-phase cultures in a phos-
phate-saline buffer. The model is called Ers treatment (en-
hanced resistance to stress) because it enhances resistance of
stationary cultures to acid, H2O2, and antibiotic stresses. Ers
treatment suppresses the defective entry into amoeba and mac-
rophage hosts of null mutants with mutations in dotA and dotB,
other icm/dot genes, and katA and katB genes. Since the icm/
dot genes are not required for host entry of Ers-treated Legio-
nella, icm/dot-independent entry factors are implicated in the
Ers treatment model. Thus, analysis of Ers treatment-induced
gene expression may be an avenue for identifying icm/dot-
independent factors involved in the entry of Legionella into
eukaryotic hosts.
MATERIALS AND METHODS
Bacterial strains and culture conditions. All L. pneumophila mutants were
derived from serotype 1 wild-type strain JR32 (66, 83) (Table 1). Legionella
strains were revived from frozen storage on charcoal–N-(2-acetamido)-2-amino-
ethanesulfonic acid (ACES)-buffered pH 6.9 yeast extract agar plates and then
cultured in ACES-buffered pH 6.9 yeast extract (AYE) broth (27, 40). Exponen-
tial- and stationary-phase cultures were grown to optical densities at 600 nm of
0.5 to 0.9 and 2.5, respectively (15). When required, chloramphenicol, hygro-
mycin sulfate, and gentamicin sulfate were present at concentrations of 5, 100,
and 10 g/ml, respectively. Ers-treated cultures were prepared by resuspension
of stationary-phase cultures in Acanthamoeba castellanii buffer (AC buffer) (50),
followed by incubation for 16 to 19 h. AC buffer contained 4 mM magnesium
sulfate, 0.4 mM calcium chloride, 3.4 mM sodium citrate, 0.051 mM ferrous
ammonium sulfate, 2.5 mM sodium monohydrogen phosphate, and 2.5 mM
potassium dihydrogen phosphate, and the pH was adjusted to 6.5 with HCl. For
recombinant construction we used Escherichia coli strain DH5 cultured in
Luria-Bertani medium (75) with chloramphenicol, hygromycin sulfate, and gen-
tamicin sulfate at concentrations of 25, 150, and 5 g/ml, respectively. All cul-
tures were incubated at 37°C with aeration. Bacterial viability was determined by
the LIVE/DEAD BacLight technique (Molecular Probes, Eugene, Oreg.).
Amoeba and macrophage lines and culture conditions. A. castellanii ATCC
30234 was cultured at 28°C in peptone yeast extract glucose (PYG) medium, as
described previously (5, 39, 71). The HL60 monocyte cell line was maintained in
RPMI medium supplemented with 2 mM glutamine, 10% heat-inactivated fetal
bovine serum, and penicillin-streptomycin (5,000 U/ml) at 37°C in a humidified
atmosphere containing 5% CO2 (39, 71).
Growth of L. pneumophila in A. castellanii. For growth of L. pneumophila in
A. castellanii (39, 71), adherent amoebae were fed with fresh PYG medium the
previous day in a 75-cm2 tissue culture flask. The PYG medium was removed
from the flask, 25 ml of AC buffer was added, and stationary-phase wild-type or
katA null mutant L. pneumophila cells were added at a multiplicity of infection
(MOI) of 3 to 5. After incubation for 1 h at 37°C, the amoeba monolayer was
washed twice and incubated for 48 h at 37°C with 25 ml of fresh AC buffer. The
AC buffer, containing Legionella released following intracellular multiplication
and lysis of the amoeba hosts, was removed. Fresh AC buffer was added, and
adherent amoebae containing intracellular bacteria were dislodged (71) and
recovered by centrifugation. The amoeba pellet was resuspended in AC buffer
and RPMI medium containing glutamine and normal human serum for stress
and HL60 entry experiments, respectively, and amoebae were lysed by repeated
aspiration through a 30-gauge needle (20, 50). Amoeba debris was removed by
centrifugation (1 min at 150  g) (20), and the supernatant containing amoeba-
grown L. pneumophila was used immediately for stress or entry experiments.
Plasmids. Transformation of L. pneumophila with plasmids (Table 1) express-
ing hygromycin resistance was accomplished by natural competence (51, 77) by
using a protocol described previously (51). All other plasmids were transformed
by electroporation by using a previously described protocol (18), modified as
follows. Cultures of L. pneumophila in AYE broth (optical density at 600 nm, 0.4
to 1.0) were centrifuged and resuspended in cold 10% glycerol three times, the
last time at a ratio of 2 ml of 10% glycerol per liter of culture. Electroporation
was performed in 0.2-cm cuvettes with a Gene Pulser (Bio-Rad, Hercules, Calif.)
set at 25 F and 2.5 kV, and this was followed by 4 to 5 h of outgrowth in AYE
broth at 37°C before plating. To perform immunofluorescence entry assays with
complemented L. pneumophila mutants, it was necessary to construct a green
fluorescent protein (GFP)-expressing plasmid compatible with the IncQ plas-
mids conventionally used for complementation. The pBBR1MCS-5 derivative of
the Bordetella bronchiseptica BHR plasmid has a pBBR/BHR replicon (45) that
is maintained in L. pneumophila (47, 48) and is compatible with IncP, IncW,
IncQ, and IncRi incompatibility groups (45). PCR primers with BglII sites at
their 5 ends were used to amplify the region outside the gentamicin cassette in
TABLE 1. Strains and plasmids used in this study
Strain or plasmid Genotype or features Reference
Strains
JR32 Salt-sensitive isolate of AM511 (Philadelphia-1 Smr rm) 66
katA (PB126) JR32 katA::Gmr 6
katB (PB117) JR32 katB:: Cmr 7
icmS (GS3001) JR32 icmS3001::Km 68
icmP (GS3002) JR32 icmP3002::Km 68
icmX (LELA921) JR32 icmX921::Tn903dIIlacZ 66
icmF (LELA1275) JR32 icmF1275::Tn903dIIlacZ 66
icmV (LELA1747) JR32 icmV1747::Tn903dIIlacZ 66
dotB (LELA2883) JR32 dotB2883::Tn903dIIlacZ 66
dotA (LELA3118) JR32 dotA3118::Tn903dIIlacZ 66
icmS complemented GS3001/pGS-Lc-37-14 71
icmP complemented GS3002/pGS-Lc-34-14 71
icmF complemented LELA1275/pGS-Lc-55-14 71
katA complemented PB126/pMMB207B-Km-14::katA 6
Plasmids
pMV206.hyg BspHI to SmaI hygromycin resistance cassette from p16R1 in pMV206 with Kmr
resistance cassette removed
33
pJN105 pBBR1MCS-5 with araC and PBAD regions before the polylinker, Gm
r 55
pJN105-hygro-GFP pJN105 with hygromycin resistance and GFP This study
pGS-Lc-37-14 icmTS in pMMB207B-Km-14 71
pMMB207 RSF1010 derivative, IncQ, oriT, lacIq, Ptac, Cmr 52
pGS-Lc-34-14 icmPO in pMMB207B-Km-14 71
pGS-Lc-55-14 icmF and tphA in pMMB207B-Km-14 71
pMMB207B-Km-14 pMMB207, lacZ, MCS, with mobA::Kmr 70
pMMB207B-Km-14::katA katA in BamHI site of pMMB207B-Km-14 opposite the direction of Ptac 6
pGS-GFP-04 gfp in pMMB207 39
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pJN105, a derivative of pBBR1MCS-5 with araC and PBAD regions before the
polylinker (55). The PCR fragment was digested with BglII, blunted with the
Klenow fragment, and ligated to the blunted DdeI-DdeI hygromycin resistance
fragment from pMV206.hygro (33) to form pJN105-hygro. The Ptac-GFP frag-
ment of pGS-GFP04 (39) was amplified by PCR by using primers with NheI sites
at their 5 ends. After digestion with NheI, this fragment was ligated with
NheI-digested pJN105-hygro to form pJN105-hygro-GFP. To our knowledge,
hygromycin has not previously been reported to be a selectable marker in L.
pneumophila.
Acid and hydrogen peroxide stress treatments. L. pneumophila cultures (ex-
ponential, stationary phase, or Ers treated stationary phase) were washed, re-
suspended in AC buffer, and diluted to the desired cell concentration by assum-
ing that an optical density at 600 nm of 0.3 corresponded to 5 108 CFU/ml (39).
For acid treatment, 0.5 ml of a bacterial suspension was rapidly mixed with 0.5
ml of 40 mM citric acid in AC buffer to obtain a final pH of 3.0. For H2O2
treatment, H2O2 was added to 1 ml of a bacterial suspension to a final concen-
tration of 1 mM. After incubation at 37°C with aeration for the desired time,
aliquots were diluted into AC buffer and then plated on CYE agar for colony
counting. Acid and H2O2 stress experiments with wild-type strain JR32 and the
katA mutant were performed three or more times. Acid stress experiments with
icmF, icmP, and icmS mutants were performed two or more times.
Immunofluorescence assay for entry of Legionella into A. castellanii and HL60-
derived macrophages. For the immunofluorescence assay for entry of Legionella
into A. castellanii (39), adherent A. castellanii cells were resuspended in PYG
medium to a concentration of 1  107 cells/ml, and then 0.5 ml was added to
wells of a 24-well tissue culture plate containing glass coverslips (diameter, 12
mm). After incubation for 1 h at 28°C in a humidified atmosphere, the PYG
medium was removed, and the amoeba monolayer was washed three times with
AC buffer. To each well 0.5 ml of AC buffer and an L. pneumophila culture in AC
buffer were added to obtain an MOI of 3 to 5. The tissue culture plate was
centrifuged at room temperature (700  g, 10 min) to synchronize the infection
and then incubated for 30 min at 28°C in a humidified atmosphere. Subsequent
washing, formaldehyde fixation, and incubation with rhodamine-conjugated rab-
bit anti-L. pneumophila serotype 1 antibody (m-Tech, Atlanta, Ga.) were per-
formed as described previously (39). Coverslips were inverted and mounted on
microscopy slides by using Fluoromount G mounting medium (Southern Bio-
technology Associates, Birmingham, Ala.).
HL60 cells were resuspended in RPMI-glutamine-PennStrep medium without
fetal bovine serum to a concentration of 3  106 cells/ml, and 0.5 ml was added
to wells of a 24-well tissue culture plate containing glass coverslips. After incu-
bation for 1 h at 37°C in a humidified 5% CO2 atmosphere, the medium was
removed, and the monolayer was incubated for 20 to 24 h in RPMI-glutamine-
PennStrep medium with 10% fetal bovine serum containing 20 nM phorbol
12-myristate 13-acetate to promote differentiation into macrophages. The mono-
layer was then washed three times with medium without PennStrep or phorbol
12-myristate 13-acetate. Then to each well 0.5 ml of RPMI-glutamine medium
containing 10% normal human AB serum (Gemini Bioproducts, Woodland,
Calif.) was added, followed by L. pneumophila in the same medium at an MOI
of 100. The tissue culture plate was centrifuged for 10 min at room temperature
and then incubated for 30 min at 37°C. Subsequent washing, formaldehyde
fixation, incubation with rhodamine-conjugated anti-L. pneumophila antibody,
and mounting were performed as described above for the fluorescence-based
A. castellanii entry experiments (39).
The L. pneumophila strains used for the immunofluorescence assay contained
one of two plasmids expressing GFP. For strains harboring plasmid pGS-GFP-04
(39), the Legionella medium contained chloramphenicol and 0.5 mM isopropyl-
	-D-thiogalactopyranoside (IPTG). For strains harboring plasmid pJN105-hygro-
GFP, the medium contained hygromycin and 0.5 mM IPTG. Whenever tested,
entry with the pGS-GFP-04 (IncQ) GFP-expressing plasmid and entry with the
pJN105-hygro-GFP (pBBR/BHR) GFP-expressing plasmid were identical. Each
amoeba or macrophage entry experiment was performed in duplicate. In addi-
tion, for amoeba entry, duplicate experiments were performed three or more
times with the JR32, katA, icmF, icmP, icmS, and dotA strains. Duplicate mac-
rophage entry experiments were performed two or more times with the JR32,
katA, icmF, icmP, icmX, and dotA strains.
Fluorescence microscopy. For fluorescence microscopy (39), microscope slides
with immunofluorescent samples were observed at a magnification of 90 by
using HiQ band-pass GFP and CY3/rhodamine filters (Chroma Technology
Corp., Brattleboro, Vt.) with an Olympus 1X70 fluorescence microscope. Only
L. pneumophila cells that are external or adherent to the host cell surface are
accessible to rhodamine-conjugated anti-serotype 1 antibody; these cells are
green with the GFP filter and red with the rhodamine filter. Legionella cells
within a host cell are not accessible to the antibody. Internalized bacteria were
defined as the bacteria within the confines of a host cell envelope that were green
with the GFP filter and not visible with the rhodamine filter. Microscope slides
could be stored in the dark at 4°C for 2 weeks prior to observation with the
fluorescence microscope without quantitative changes in the phagocytic index
(number of bacteria internalized per 50 host cells).
Gentamicin protection assay of entry into HL60-derived macrophages. For the
gentamicin protection assay of entry into HL60-derived macrophages (39), HL60
monocytes (1.5  106 cells/well) were plated, differentiated, washed, and incu-
bated with L. pneumophila cultures at an MOI 100 as described above for the
immunofluorescence method, except that no glass coverslips were added to the
24-well tissue culture plates. Following 10 min of synchronizing centrifugation
and an additional 30 min of incubation at 37°C, the HL60 monolayers were
washed twice with phosphate-buffered saline and then incubated for 40 min at
37°C with RPMI-glutamine medium with 100 g of gentamicin per ml to kill ex-
ternal, adherent Legionella. The monolayers were washed twice with phosphate-
buffered saline and lysed for 30 min with 0.5 ml of water to release internalized
bacteria. Aliquots of lysates were plated on CYE agar for colony counting.
Negative-stain electron microscopy. Cultures of the L. pneumophila dotA and
icmS null mutants in AYE broth or after Ers treatment were transferred to
Formvar- and carbon-coated grids and negatively stained with 1% phosphotung-
stic acid or 1% ammonium molybdate. The grids were blotted dry and immedi-
ately observed with a JEOL 1200 EX transmission electron microscope at 80 kV.
Images for different strains and culture conditions were compared by measuring
cell width and length, by observing features of the cell periphery from stain
pooled along the cell edges, and by observing the speckling over the cell body
from stain pooled in involutions on the cell surface.
Two-dimensional gel electrophoresis. Cell extracts were prepared from broth-
grown stationary-phase cultures and Ers-treated stationary-phase cultures by
resuspending bacteria in 25 mM potassium phosphate (pH 7.1) containing 1 mM
EDTA and 1 Complete EDTA-free protease inhibitor cocktail (Boehringer,
Indianapolis, Ind.), followed by sonication (76) and centrifugation at 15,000  g
for 40 min. Supernatant proteins were precipitated by phenol-ethyl ether extrac-
tion (67) and then dissolved at a concentration of 
8 mg ml1 in isoelectric
focusing buffer containing 9 M urea, 2% Triton X-100, 2% dithioerythritol, 0.5%
IPG buffer, and pH 4-7L Immobiline strips (Amersham Biosciences, Piscataway,
N.J.). The pH 4-7L Immobiline strips (13 cm) were hydrated with a solution
containing
2 mg of protein for 14 h at 20°C and subjected to isoelectric focusing
in an IPGphor apparatus (Amersham Biosciences), typically for a total of 40,000
V  h. After isoelectric focusing, each strip was equilibrated with 10 ml of 50 mM
Tris HCl (pH 8.8)–6 M urea–30% glycerol–2% sodium dodecyl sulfate (SDS)–
2% dithioerythritol for 40 min at room temperature and then incubated for an
additional 15 min after addition of iodoacetamide to a final concentration of
2.5%. The strips were then placed in 0.5% agarose on top of 10% acrylamide–
SDS gels. After electrophoresis, the gels were stained with 0.05% Coomassie
brilliant blue in 7% acetic acid–50% methanol, destained in 7% acetic acid–50%
methanol, and then soaked overnight in water and stored at 4°C until they were
used for protein identification.
Protein identification by mass spectrometry. Spots of interest that were cut
from acrylamide gels following two-dimensional electrophoresis were washed
once with 25% acetonitrile in 25 mM Tris HCl (pH 8.5) and twice with 50%
acetonitrile in 25 mM Tris HCl (pH 8.5) and then dried under a vacuum and
stored at 20°C. For trypsin digestion, each gel spot was incubated overnight at
32°C in 8 l of sequencing grade modified trypsin (0.01 mg ml1 in 25 mM Tris
HCl [pH 8.5]; Promega, Madison Wis.) and 15 l of water. The peptides in the
digestion buffer plus those extracted from the gel with 2% trifluoroacetic acid in
50% acetonitrile were dried under a vacuum and then dissolved in a 4-hydroxy-
-cyanocinnamic acid matrix solution (10 mg ml1 in 0.1% trifluoroacetic acid–
50% acetonitrile) and applied to a matrix-assisted laser desorption ionization–
time of flight (MALDI-TOF) mass spectrometer sample plate. The masses of
tryptic peptides in digestion mixtures were determined by MALDI-TOF mass
spectrometry with a Voyager-DE mass spectrometer (PerSeptive Biosystems,
Inc. Farmingham, Mass.). Proteins in gel spots were identified by matching
experimentally determined masses with masses predicted from open reading
frames (ORFs) in the L. pneumophila strain JR32 genome (http://genome3.cpmc
.columbia.edu/
legion/index.html) by using the Peptide Search Program (http:
//www.narrador.embl-heidelberg.de/GroupPages/PageLink/peptidesearchpage
.html). Unambiguous matches were established by considering the number of
peptides matched, the percentage of the ORF covered, the matched uncleaved
peptides, and the agreement between the experimental and predicted masses and
the isoelectric points for the S-acetamidomethylated polypeptide.
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RESULTS
Intra-amoebic growth enhances resistance of wild-type
L. pneumophila to acid and H2O2 stresses. Intracellular mul-
tiplication of L. pneumophila in environmental amoebae is
integral to the spread of Legionnaires’ disease (3, 8, 74, 80).
We examined if intracellular multiplication in A. castellanii—
known to enhance entry of L. pneumophila into macrophage
and amoeba hosts (19, 20)—enhanced the resistance of Legio-
nella stationary-phase cultures used to infect amoebae to H2O2
and acid stresses. Since Legionella is likely to encounter reac-
tive oxygen species following phagocytosis (5, 35, 41, 46) and to
encounter acid stress when Legionella-containing phagosomes
ultimately fuse with lysosomes (78), these stresses are physio-
logically relevant.
Amoeba-grown Legionella maintained an approximately
constant titer after challenge by pH 3 (Fig. 1A) or 1 mM H2O2
(Fig. 1B). In contrast, the titers of broth-grown stationary-
phase cultures decreased by more than 5 orders of magnitude
and by 2 orders of magnitude, respectively. Exponential-phase
cultures were considerably less resistant to acid and H2O2
stresses than stationary-phase cultures (Fig. 1). This cross-
resistance of stationary-phase cultures to stress, initially ob-
served in E. coli (42), is also found in L. pneumophila (4, 36).
Wild-type L. pneumophila strain AA100 showed increases in
resistance to acid, H2O2, osmotic, and thermal stresses in bac-
teria isolated after intracellular multiplication in Hartmannella
vermiformis compared with the resistance of exponential-phase
broth cultures (2). Our demonstration of increased stress re-
sistance following intra-amoebic growth is in qualitative agree-
ment with the results of H. vermiformis studies (2). However, a
quantitative comparison was not possible due to differences in
the stress resistance of the stationary-phase and exponential-
phase cultures to which the amoeba-grown Legionella cells
were compared.
Identification of enhanced resistance to stress (Ers treat-
ment). Intracellular multiplication of L. pneumophila in the
amoeba Acanthamoeba polyphagia enhances resistance to an-
tibiotic and biocide stresses (9, 10). In the previous studies,
amoeba-grown bacteria were isolated from the medium 3 days
after infection. Legionella replicates intracellularly, lyses the
amoeba host, and begins to be released into the infection
medium within a few hours after infection (5, 36, 71). Thus, the
amoeba-grown bacteria used for antibiotic and biocide studies
were exposed for as long as 3 days to the infection medium, a
neutral-pH phosphate-saline buffer that does not support L.
pneumophila replication. It is possible that incubation in the
infection medium—without prior exposure to amoebae—con-
tributes to phenotypic changes attributed to intra-amoebic
growth. In our experiments (Fig. 1) and in the experiments
with H. vermiformis (2), intra-amoebic L. pneumophila cells
were recovered by shear or osmotic lysis of the amoebae, and
any bacteria released into the infection medium by bacterial
lysis of amoebae were removed and not used for stress studies.
We tested if resistance to acid and H2O2 stresses is enhanced
by incubation of Legionella in the infection medium for A.
castellanii, AC buffer (5, 19, 20, 50, 71), a phosphate-saline
buffer similar to A. polyphagia infection medium (2). Incuba-
tion in AC buffer in the absence of amoebae significantly in-
creased the resistance of stationary-phase L. pneumophila cul-
tures to pH 3 and H2O2 (Fig. 1). We called this incubation in
AC buffer Ers treatment (enhanced resistance to stress) to
indicate its effect on resistance of stationary-phase cultures to
acid and H2O2.
Ers treatment enhances stress resistance of Legionella katA
and icm/dot mutants. Mutants with defective virulence pheno-
types were not examined in prior studies of the effect of in vitro
and intra-amoebic growth on stress resistance (2, 9, 10). There-
fore, we examined the effects of these growth conditions on an
L. pneumophila periplasmic catalase-peroxidase mutant with a
Gmr element inserted in the katA gene. This mutant is defec-
tive in intracellular multiplication in primary macrophages,
macrophage lines, and A. castellanii (5, 6). Stationary-phase
cultures of the katA oxidative stress response mutant were
considerably more sensitive than wild-type stationary cultures
to pH 3 and H2O2 stresses (compare Fig. 2 with Fig. 1). How-
ever, Ers treatment restored the level of resistance of the katA
mutant to that of wild-type stationary-phase cultures for both
acid and H2O2 stresses (compare Fig. 2 with Fig. 1).
Next, the effect of growth conditions on acid resistance was
examined in icm/dot mutants defective in intracellular multi-
plication in HL60-derived macrophages and A. castellanii (icmF,
icmP, and icmS Tn insertion mutants) (71). (Fig. 3) Ers treat-
ment increased the level of resistance to that of Ers-treated
wild-type Legionella for the icmF and icmP mutants, while the
icmS mutant was not responsive to Ers treatment. Restoration
of the response to Ers treatment in the complemented icmS
mutant shows that loss of the response is related to inactivation
of icmS. These results suggest that icmS is essential for the
FIG. 1. Effect of growth conditions on stress resistance of wild-type
L. pneumophila. Exponential-phase (Exp), stationary-phase (Stat), or
Ers-treated stationary-phase (Ers) cultures or bacteria recovered from
A. castellanii following intracellular multiplication (Acca) were chal-
lenged with pH 3 (A) or 1 mM H2O2 (B) and titrated after different
times (mean  standard deviation). The points plotted on the x axis
are the values when there were no CFU.
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stress response to Ers treatment but that neither katA, icmF,
nor icmP is required. Since for all mutants there was increased
resistance of stationary-phase cultures compared to exponen-
tial-phase cultures, neither katA, icmF, icmP, nor icmS is required
for the cross-resistance stress phenotype (Fig. 2 and 3).
Ers treatment suppresses the defective entry of katA, katB,
and dot/icm mutants into amoebae. The entry of amoeba-grown
wild-type L. pneumophila into A. castellanii is increased 10-fold
compared to the entry of stationary-phase bacteria (20). The
amoeba-grown bacteria used for this study were isolated from
the AC buffer infection medium following lysis of amoeba
hosts by Legionella. Since both intra-amoebic growth and Ers
treatment enhanced the acid and H2O2 resistance of wild-type
Legionella (Fig. 1), we examined if Ers treatment enhanced
entry into A. castellanii. No significant change in entry was seen
following Ers treatment of wild-type Legionella (Fig. 4A).
We next examined if Ers treatment enhanced entry of katA
and icm mutants, mutants that exhibited defective intracellular
multiplication in A. castellanii. Consistent with previous results
obtained by using fluorescence microscopy (39), icmF, icmP,
and icmS mutants were reduced in entry when stationary-phase
cultures of Legionella were used to infect A. castellanii (Fig.
4A). Defective entry for the katA mutant was not examined
previously. Remarkably, entry of the katA, icmF, and icmP
mutants was increased 10- to 30-fold when Ers-treated station-
ary-phase cultures were used to infect A. castellanii (Fig. 4A).
Ers treatment restored entry of the katA mutant to wild-type
values, and entry of icmF and entry of icmP were restored to
40% of the wild-type values. These effects parallel the effects of
Ers treatment on stress resistance in that the katA, icmF, and
icmP mutants (Fig. 2 and 3A and B) were responsive, while the
icmS mutant was not affected by Ers treatment (Fig. 3C).
When the icm mutants were complemented with wild-type al-
leles on plasmids, entry of stationary-phase cultures was no longer
defective compared to entry of wild-type strain JR32 containing
the empty complementing vector (Fig. 4B). These findings are
consistent with the results of previous studies that demonstrated
complementation of the entry defect in stationary-phase cultures
(39). Similarly, the entry of Ers-treated complemented mutants
was not significantly different from the entry of the wild type
containing the empty vector (Fig. 4B). The complementation data
demonstrated that suppression of defective entry by Ers treat-
ment was associated with loss of function of the katA, icmF, and
icmP genes and was unlikely to be associated with spontaneous
mutations outside the inactivated genes.
To ascertain if Ers treatment suppresses defective entry of
other Legionella mutants, we examined a katB null mutant,
whose intracellular multiplication phenotype was like that of
the katA mutant (5, 6), and null mutants with mutation in four
other icm/dot genes. One of these was a dotA mutant, with a Tn
insertion in the dotA gene, required for many aspects of Le-
gionella virulence when stationary-phase cultures are used for
infection, from entry through cytotoxicity to the host cell (11,
43, 44, 63, 64). All five mutants exhibited statistically significant
FIG. 2. Effect of growth conditions on the stress resistance of the
katA null mutant. Exponential-phase (Exp), stationary-phase (Stat), or
Ers-treated stationary-phase (Ers) cultures of the katA::Gmr null mu-
tant or bacteria recovered from A. castellanii following intracellular
multiplication (Acca) were challenged with pH 3 or 1 mM H2O2 and
titrated after different times (mean  standard deviation). The points
on the x axis are the values when there were no CFU.
FIG. 3. Effect of growth conditions on acid resistance of icm null
mutants. Acid challenge experiments were performed with icmF (A),
icmP (B), and icmS (C) null mutants. Exponential-phase (Exp), sta-
tionary-phase (Stat), or Ers-treated stationary-phase (Ers) cultures
were challenged with pH 3 and titrated after different times (mean 
standard deviation). Ers compl, Ers-treated stationary-phase culture of
icmS mutant containing an icmS complementing plasmid. The points
on the x axis are the values when there were no CFU.
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increases in entry following Ers treatment, which ranged from
3- to 4-fold for the icmX and dotA mutants to 40-fold for the
katB mutant (Fig. 4A). Moreover, Ers treatment restored the
levels of entry to 50% of the wild-type value for the katB,
icmV, dotA, and dotB mutants and to 30% of the wild-type
value for the icmX mutant.
These data show that the defective entry of katA, katB, icmF,
icmP, icmV, icmX, dotA, and dotB mutants into A. castellanii is
conditional and dependent on culture conditions. The entry def-
icit was evident in stationary-phase cultures, as described previ-
ously (39), but was suppressed by Ers treatment of stationary-
phase cultures. To our knowledge, suppression of an entry
defect by varying the culture conditions of a Legionella icm/dot
or other virulence mutant has not been reported previously.
Ers treatment suppresses the defective entry of katA, katB,
and icm/dot mutants into HL60-derived macrophages. Many
L. pneumophila icm/dot mutants are defective in entry (39) and
in intracellular multiplication (71) in both macrophages and
amoeba hosts. We therefore examined if Ers treatment, which
suppressed the defective entry of stationary-phase cultures of
katA/B and icm/dot mutants into amoebae, similarly sup-
pressed the defective entry into HL60-derived macrophages.
Consistent with previous work (39), stationary-phase cultures
of icm/dot mutants exhibited decreased entry into HL60-de-
rived macrophages (Fig. 5). Ers treatment did indeed suppress
the defective entry of katA, katB, icmF, icmV, icmX, dotA, and
dotB null mutants into macrophages. Statistically significant
two- to ninefold increases were seen, and for all mutants entry
into macrophages was restored to wild-type levels. Entry of the
icmP mutant into macrophages was not significantly changed,
and entry of the icmS mutant was decreased.
Intra-amoebic growth suppresses the defective entry of the
katA virulence mutant into HL60-derived macrophages. Only
wild-type L. pneumophila cells were used in previous studies
that demonstrated enhanced entry into macrophage and amoeba
hosts following intra-amoebic growth (19, 20). To examine the
effect of intra-amoebic growth on a Legionella mutant with
defective intracellular multiplication, we used the katA mutant,
which replicates in A. castellanii at a reduced rate (5) and was
defective in amoeba and macrophage entry (Fig. 4A and 5).
The dotA mutant and most other icm/dot Tn insertion mutants
were unsuitable for this experiment because they are nonrep-
licative in A. castellanii (71). This is likely why only wild-type L.
pneumophila was examined in previous studies of phenotypic
changes following intra-amoebic growth (9, 10, 19, 20, 32).
A. castellanii was infected with wild-type or katA Legionella,
and intracellular bacteria were isolated 2 days later by shear
lysis of the amoeba host, as was done for isolation of amoeba-
grown Legionella for the acid and H2O2 stress experiments
(Fig. 1). Entry into HL60-derived macrophages was quantified
by examining the gentamicin protection, the method used pre-
viously to show enhanced entry of amoeba-grown wild-type
Legionella (19, 20). The 8.1-fold increased entry of wild-type
L. pneumophila which we found is in good agreement with the
previously described 10-fold increased entry of amoeba-grown
wild type into cultured macrophage lines (20). Entry of the
katA mutant was increased 12-fold, in good agreement with the
9.3-fold increase determined by GFP fluorescence after Ers
FIG. 4. Ers treatment reverses the defect in entry of katA, katB,
and icm/dot mutants into A. castellanii. A. castellanii was infected at an
MOI of 3 to 5 with wild-type L. pneumophila strain JR32 or a mutant
strain grown to the stationary phase (Stat) or after Ers treatment of
stationary-phase cultures (Ers). Internalized bacteria were quantified
by the fluorescence microscopy method (mean  standard deviation).
(A) Strains containing a GFP-expressing plasmid. (B) Strains con-
taining the pJN105-hygro-GFP plasmid and a second plasmid,
pMMB207B-Km14 for wild-type strain JR32 or a complementing
plasmid for mutant strains. P values were determined by one-sided t
tests by comparing entry of stationary-phase and Ers-treated cultures
of the same strain (A) or by comparing a mutant stationary-phase or
Ers-treated culture with a similar wild-type culture (B) (two asterisks,
P  0.005; one asterisk, P  0.02; no asterisk, P  0.05).
FIG. 5. Ers treatment reverses the defect in entry of katA, katB,
and icm/dot mutants into HL60-derived macrophages. The entry of
wild-type strain JR32 or a mutant strain into macrophages derived
from HL60 monocytes (MOI, 100) was determined as described for
entry into A. castellanii in the legend of Fig. 4. P values were deter-
mined by one-sided t tests by comparing entry of stationary-phase
(Stat) and Ers-treated (Ers) cultures of the same strain (one asterisk,
P  0.05; two asterisks, P  0.005; no asterisk, P  0.05).
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treatment of this mutant (Fig. 5). Thus, intra-amoebic growth,
like Ers treatment, can suppress the defective entry of the
Legionella katA null mutant.
Ers treatment increases antibiotic resistance of wild-type
and dotA mutant L. pneumophila. Increased resistance to bio-
cides used in water purification and to antibiotics used to treat
Legionella infections, including erythromycin (65), is shown by
Legionella grown in the amoeba A. polyphagia (9, 10). Since
both intra-amoebic growth and Ers treatment increased resis-
tance to acid and H2O2 stresses (Fig. 1) and suppressed de-
fective entry of the katA mutant, we examined if Ers treatment
increased antibiotic resistance.
The resistance of wild-type Legionella to gentamicin and
erythromycin was increased 400- and 2-fold, respectively, fol-
lowing Ers treatment of stationary-phase cultures (Table 2).
The resistance of the dotA Tn insertion mutant to gentamicin,
erythromycin, and rifampin was increased 20-, 5-, and 95-fold,
respectively, by Ers treatment. Previous studies reported that
intra-amoebic growth increased resistance to erythromycin and
rifampin 100- and 1,000-fold, respectively, for wild-type Legio-
nella (10), but icm/dot mutants were not examined. In the
previous studies the workers used 10- to 20-fold-lower drug
concentrations and resuspended Legionella in fresh broth dur-
ing the 6 to 24 h of antibiotic challenge. In our experiments
stationary-phase or Ers-treated cultures were exposed to anti-
biotics for 40 min in AC buffer, which does not support Legio-
nella growth. Thus, the Ers-induced increase in antibiotic resis-
tance is qualitatively similar to that observed for intra-amoebically
grown Legionella (10), but quantitative comparisons are not
possible due to differences in experimental design.
In the studies that demonstrated increased antibiotic resis-
tance following intra-amoebic growth, L. pneumophila cells
were isolated from the infection medium 3 days after infection
of A. polyphagia (10). As noted above, Legionella begans to be
released into the medium within a few hours after infection of
amoebae. The 16- to 19-h duration of Ers treatment, in which
Legionella was exposed to a phosphate-saline buffer similar to
the A. polyphagia infection medium (10), is within the 3-day
time frame of exposure to infection medium in the A. poly-
phagia studies. Therefore, exposure to the infection medium
following Legionella lysis of amoeba hosts may have contrib-
uted to the increased antibiotic resistance previously attributed
to intra-amoebic growth (10).
Mechanistic aspects of Ers suppression of mutant pheno-
types in katA, katB, and icm/dot Legionella mutants Ers treat-
ment suppressed defective entry associated with null mutations
in a diverse group of genes encoding structural and chaperone
components of the Icm/Dot type IVB secretion apparatus (22,
63, 69, 74, 80) and catalase-peroxidase enzymes. To investigate
the mechanism(s) by which suppression was accomplished, we
first considered the possibility that Ers treatment induces mul-
tiple icm/dot genes, which then compensate for inactivation of
individual icm/dot genes. This mechanism is unlikely because
several icm::lacZ translational fusions show no significant
change in expression during incubation of stationary-phase
cultures in AC buffer (Gil Segal, Tel Aviv University, 2004,
personal communication). In addition, induction of icm/dot
genes is an unlikely mechanism for suppression of entry defects
in mutants with mutations in KatA and KatB catalase-peroxi-
dase enzymes that are not components of the Icm/Dot type
IVB secretion machinery. Second, we considered the possibil-
ity that Ers treatment enhances adhesion of Legionella to host
cells, thus enhancing entry. This possibility is not supported by
the results obtained by the fluorescence microscopy method
that distinguished internalized bacteria from external bacteria.
Specifically, Ers treatment does not increase association of
external L. pneumophila with amoebae or macrophage enve-
lopes. Third, we considered the possibility that Ers treatment
increases piliation, which has recently been implicated in entry
by isolation of a gene with homology to the genes encoding
pilin subunits of type IV secretion systems (60). This possibility
is not supported by the results of electron microscopy with
phosphotungstate and ammonium molybdate negative stain-
ing. No difference in piliation was seen between stationary-
phase and Ers-treated cultures of the dotA mutant, which re-
sponded to Ers treatment, or the icmS mutant, which did not
respond to Ers treatment (data not shown). Fourth, we con-
sidered the possibility that Ers treatment changes the bacterial
surface morphology, eliciting changes responsible for en-
hanced entry. This possibility is not supported by electron
microscopy data for stationary-phase and Ers-treated cultures
of dotA and icmS mutants. In both mutants and in both culture
conditions, the cell envelope is smooth and unruffled, and the
speckling patterns that are reflective of involutions in the cell
surface are comparable. The cell widths are identical for the
two mutants and are not changed by the culture conditions,
and the cell length is shorter in Ers-treated cultures, which is
consistent with starvation, utilization of energy stores, and
decreased entry into a replicative state (data not shown). The
dramatic differences in cell morphology seen in amoeba-grown
TABLE 2. Effect of Ers treatment on the antibiotic resistance of stationary-phase Legionellaa
Antibiotic Concn(g/ml)
JR32 dotA mutant
% Survival
Ers/Stat
% Survival
Ers/Stat
Stat Ers Stat Ers
Gentamicin 100 1.75  103  1.2  103 0.73  0.41 420 0.041  0.0042b 0.87  0.06 21
Erythromycin 100 19  2 46  16 2.4 2.5  0.9 12  6 4.8
Rifampin 100 54  0.5 69  16 1.3 0.74  0.04 70  11 95
a Bacteria in the stationary phase (Stat) or following Ers treatment after the stationary phase (Ers) were resuspended in phosphate-buffered saline at a concentration
of 1 108 to 5 109 CFU/ml, incubated at 37°C for 40 min with the concentration of antibiotic indicated, and then titrated on CYE plates. The titer obtained compared
to titer before antibiotic treatment is expressed as the percent survival; the values are means  standard deviations.
b The higher level of survival of the stationary-phase dotA mutant than of stationary-phase strain JR32 is attributable to the kanamycin resistance element in
dotA::Tn903, which conveys a low level of gentamicin resistance.
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Legionella by light and electron microscopy (20, 32) are not
evident in Ers-treated cultures. Fifth, we considered the pos-
sibility that Ers treatment decreases viability and that en-
hanced entry can be attributed to increased phagocytosis of
dead bacteria. This possibility is not consistent with the viabil-
ity measurements. The levels of viability of broth-grown sta-
tionary-phase cultures of wild-type strain JR32 and the katA
and dotA mutants are 95%  5%, 92%  3%, and 96%  4%,
respectively. The levels of viability of Ers-treated broth cul-
tures are 94%  5%, 95%  2%, and 94%  2%, respectively.
Thus, Ers treatment does not significantly decrease the viabil-
ity of broth-grown stationary-phase cultures, and high levels of
viability are evident in both stationary-phase and Ers-treated
cultures.
Protein expression differences between stationary-phase L.
pneumophila and intra-amoebically grown bacteria are evident
as determined by SDS-polyacrylamide gel electrophoresis (20).
To establish if protein expression is required for Ers suppres-
sion of defective entry, entry into A. castellanii was determined
for stationary-phase cultures and for stationary-phase cultures
exposed to Ers treatment in the absence or in the presence
chloramphenicol (Fig. 6). Chloramphenicol inhibition of pro-
tein synthesis abolished Ers treatment-enhanced entry of katA
and icmF mutants. Entry of wild-type Legionella into amoebae
was not significantly altered by Ers treatment in the absence or
presence of chloramphenicol. These results demonstrated that
protein synthesis occurs during Ers treatment and is required
for Ers suppression of the entry defect in katA and icmF mutants
and presumably is required for suppression of other mutants.
Proteomic analysis of Ers treatment-induced changes in
expression. To directly examine expression changes implicated
in the chloramphenicol inhibition experiments, stationary-
phase and Ers-treated L. pneumophila cultures were compared
by using two-dimensional gel electrophoresis, MALDI-TOF
analysis of tryptic digests, and data mining of the L. pneumo-
phila genome. This approach has been used with other bacte-
rial species to assess changes in protein expression in different
culture conditions (12, 34, 56, 82). Two-dimensional gels were
prepared by using proteins in sonic extracts of katA, dotA,
dotB, icmF, icmS, and icmP mutant strains.
Intensity differences between stationary-phase and Ers-
treated cultures were consistently seen in about 15 spots. One
protein whose level was consistently decreased after Ers treat-
ment is the Legionella homologue of cell division protein FtsZ,
ORF lpg 2609 in the L. pneumophila genome (James Russo,
Columbia Genome Center, personal communication). A de-
crease in the FtsZ level is consistent with the decreased repli-
cation expected in cultures exposed to Ers treatment, in which
stationary-phase bacteria are incubated in a nutrient-deficient
buffer. The decreased expression of FtsZ after Ers treatment is
consistent with electron microscopy changes in cell length that
are suggestive of decreased replication after Ers treatment. All
strains whose defective entry into macrophages was suppressed
by Ers treatment (katA, dotA, dotB, and icmF mutants) (Fig. 5)
showed a large increase in the intensity of a spot in Ers-treated
cultures compared to stationary-phase cultures (Fig. 7). In
strains whose defective entry into macrophages was not sup-
pressed by Ers treatment (icmP and icmS mutants) (Fig. 5), the
FIG. 6. Chloramphenicol inhibits Ers-enhanced entry into A. cas-
tellanii for icmF and katA mutants. Entry into A. castellanii was deter-
mined for wild-type strain JR32 and icmF and katA mutant strains as
described in the legend to Fig. 4 with stationary-phase cultures (Stat),
Ers-treated stationary-phase cultures (Ers), and Ers-treated stationary-
phase cultures in the presence of chloramphenicol (ErsCm and Ers 
Cm).
FIG. 7. Two-dimensional gel electrophoresis analysis of L. pneumophila katA mutant. Isoelectric focusing (horizontal) and SDS-polyacrylamide
gel electrophoresis (vertical) were performed with sonic extracts from stationary-phase (A) and Ers-treated stationary-phase (B) cultures. The
regions shown are 
20% of each gel surrounding ORF lpg2222 (arrows) (calculated molecular weight, 41,400; calculated pI 5.35). The amount
of protein loaded in panel A was greater than the amount loaded in panel B.
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intensity of the spot was not increased by Ers treatment. The
protein in this spot, ORF lpg2222 in the L. pneumophila ge-
nome (Russo, personal communication), is predicted (49; http:
//www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml) to contain
eight consecutive tetratricopeptide repeats (TPRs) (13) and is
highly homologous (E value, e25) to known TPR proteins.
The TPR motif is a degenerate repeat consisting of
34 amino
acids that functions in protein-protein interactions, often in
multiprotein complexes. This motif is found in yeast transcrip-
tion factors, eukaryotic chaperones involved in protein import
to peroxisomes, and mitochondria (13) and has recently been
implicated in chaperones and regulators of bacterial type III
secretion systems (57).
DISCUSSION
Environmental stress plays a major role in the transition of
L. pneumophila from a planktonic pond resident to an intra-
cellular pathogen of alveolar macrophages. In the laboratory,
growth to the stationary phase is widely used to model this
stress-induced transition. When stationary-phase cultures are
used as the infectious inocula, Legionella homologues of en-
teric regulators of stress, starvation, and/or stationary-phase
responses play a role in expression of intracellular multiplica-
tion and other Legionella virulence phenotypes. Among these
regulators are L. pneumophila homologues of RpoS (4, 36, 84),
an alternative sigma factor, GacA (LetA) (31, 37), a global
activator, and CsrA (28, 51), an RNA-binding protein in the
carbon starvation response.
A major focus in studying the pathways connecting stress
with virulence phenotypes is the icm/dot loci, which encode a
type IVB secretion apparatus proposed to translocate Legio-
nella proteins into host cells. The type IVB apparatus and its
translocated proteins are involved in entry, evasion or delay of
fusion between lysosomes and Legionella-containing phago-
somes, association of the phagosome with the endoplasmic
reticulum, intracellular multiplication, cytotoxicity, and the re-
lease of replicated bacteria from host cells (63, 69, 73, 80).
However, Legionella RpoS and GacA have no significant effect
on the expression of the icm/dot transcriptional units (31, 84).
CpxR, a regulator of the enteric response to envelope stress
(58), activates expression of IcmR (30), which influences for-
mation of pores or channels in host cells by IcmQ (26). The
effect of CsrA on icm/dot gene expression has not been re-
ported. Since these stress regulators have a limited effect or no
effect on expression of the icm/dot genes, they appear to con-
trol non-icm/dot virulence genes outside the icm/dot loci.
The presence of icm/dot-independent virulence genes is in-
dicated by data showing that certain attributes of the Legio-
nella-containing phagosome do not require a functional Icm/
Dot apparatus. DotA, an essential component of the Icm/Dot
secretion apparatus (11, 43, 44, 63, 64), and DotB (72) are not
required for the delayed acquisition of cathepsin D or Texas
Red ovalbumin lysosomal markers by Legionella-containing
phagosomes (43). These findings indicate that icm/dot-inde-
pendent genes are present. Icm/Dot-independent genes are
non-icm/dot genes that play a role in Legionella virulence phe-
notypes in the absence of fully functional icm/dot genes. The
identities of such icm/dot-independent genes and methods to
screen for them are poorly defined.
In this paper we propose Ers treatment as an avenue for
identifying icm/dot-independent Legionella virulence factors.
In Ers treatment, broth-grown stationary-phase cultures are
incubated overnight in AC buffer, a pH 6.5 phosphate-saline
buffer which does not support replication of L. pneumophila
(39, 50, 71). When stationary-phase cultures of icm/dot mu-
tants are used for infection, defective entry into amoeba
and macrophage hosts is observed (39). When the same
icm/dot mutants are subjected to Ers treatment, entry into
both amoeba and macrophage hosts is significantly increased.
Entry is restored to wild-type or nearly wild-type values for
dotA, dotB, icmF, icmV, and icmX Tn insertion mutants. Ers
treatment also significantly increases and restores to wild-type
values the entry of null mutants with mutations in the katA-
and katB-encoded catalase-peroxidase enzymes, which are sim-
ilarly defective in entry when stationary-phase cultures are
used for infection. To our knowledge, Ers treatment is the first
instance of suppressing a virulence defect in an L. pneumophila
mutant by a change in culture conditions. For a null mutant
with a mutation in the Legionella general stress gene, gspA,
intra-amoebic growth suppresses sensitivity to oxidative, osmot-
ic, acid, and thermal stresses (2). However, the gspA mutant is
not defective in intracellular multiplication and cytotoxicity.
Ers suppression of defective entry indicates that Ers treat-
ment-induced changes in gene expression can restore entry
into amoeba and macrophage hosts to wild-type values in the
absence of the icm/dot or the catalase-peroxidase gene that is
inactivated. Therefore, Ers treatment is a screening procedure
for icm/dot-independent factors that act in Legionella entry
into eukaryotic hosts, an early step in Legionella pathogenicity.
A remarkable feature of Ers treatment is its pleiotropic nature.
Ers treatment suppresses defective entry into both amoebae
and HL60-derived macrophages. It restores entry for mutants
with mutations in catalase-peroxidase enzymes (periplasmic
KatA and cytosolic KatB) (6) and membrane-associated
(DotA, IcmV), cytosolic (DotB), and predicted periplasmic
(IcmX) components of the type IVB secretion apparatus (69).
Thus, identifying the molecular players in Ers treatment sup-
pression and their mechanism of action may lead to new in-
sights into L. pneumophila pathogenicity.
Since protein synthesis is required for Ers suppression, anal-
ysis of expression differences between stationary-phase and
Ers-treated cultures is a means of investigating the mechanism
of Ers suppression and identifying icm/dot-independent viru-
lence factors. We developed a proteomic approach for identi-
fying Ers-induced expression changes and observed Ers-depen-
dent induction of ORF lpg2222 in the L. pneumophila genome.
The ORF lpg2222 protein is predicted to contain TPRs. This
protein-protein interaction motif is also present in EnhC
(ORF lpg2639), previously associated with enhanced entry in a
screening of mutagenized L. pneumophila strain AA100 for
enhanced entry into macrophage and epithelial cell hosts (21).
Enhanced entry of the enhC mutant is attributed to elevated
enhC expression. A comparison of enhC mutant and wild-type
stationary-phase cultures revealed no difference in pili or fla-
gella, similar to the results obtained when we compared sta-
tionary-phase and Ers-treated L. pneumophila. It is not known
if enhC is upregulated by Ers treatment, if elevated expression
of enhC suppresses the defective entry of dotA, dotB, and other
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icm/dot mutants, or if expression of enhC or ORF lpg2222 is
influenced by Legionella stress regulators.
Association of two TPR-containing proteins with entry into
macrophage hosts raises the possibility that the TPR motif is
important for protein-protein interactions in this step in Le-
gionella infection. EnhC contains 13 TPR motif regions (49;
http://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml). ORF
lpg 2222 contains eight TPR motifs, one 35 residues long and
seven 36 residues long. Initially found in yeast cell division
cycle proteins, TPR motifs participate in protein-protein inter-
actions of transcription factors and cochaperones and in the
import of proteins into the matrix of peroxisomes and mito-
chondria (13). Recently, TPR motifs have been predicted in
known chaperones and regulators of the bacterial type III
secretion apparatus (57). However, no TPRs are predicted (49;
http://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml) in VirE1
and IcmR, which are known chaperones in the type IVB se-
cretion systems of Agrobacterium tumefaciens (24) and L. pneu-
mophila (22, 25). Knowledge of the protein partners with
which the TPR motif proteins EnhC and ORF lpg2222 inter-
act—whether they interact with Icm/Dot proteins, with one
another, or with novel proteins—is important information for
determining their roles in the entry of L. pneumophila into host
cells. For ORF lpg2222, this information may also provide
insight into the icm/dot-independent factors that act in sup-
pression of defective entry of icm/dot and katA/B Legionella
mutants into amoeba and macrophage hosts by Ers treatment.
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